InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,633.91
(
0.00%
)
US TECH 100
20,176.80
(
0.29%
)
Dow Jones
39,721.36
(
0.00%
)
Brent Oil
84.98
(
-0.09%
)
Bitcoin
58,809.15
(
1.82%
)
Post# of 252561
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120016
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: micahlance post# 203495

Tuesday, 08/16/2016 10:17:09 AM

Tuesday, August 16, 2016 10:17:09 AM

Post# of 252561
I prefer to invest in biotechs where there is no significant risk that the mechanism-of-action doesn't work. This means that the companies I choose tend to be less sexy than those followed by some of the other contributors on this board.

RVNC is a case in point. The MoA of botulinum-toxin is well known, and there is a high probability, IMO, that RVNC's RT002 will make it to market (#msg-123290722).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up